Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 1394-1398, October 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, C. G.
Right arrow Articles by Grady, J. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smith, C. G.
Right arrow Articles by Grady, J. E.

Studies on the Mode of Action of Streptovitacin A*

Charles G. Smith, William L. Lummis and Joseph E. Grady

( Research Laboratories, The Upjohn Company, Kalamazoo, Michigan)

Streptovitacin A was shown to induce a lag phase in KB human epidermoid carcinoma cells which lasted approximately 24 hours. The cells then grew out at the normal rate.

At the time when KB cells overcame the streptovitacin A inhibition, cytotoxic activity was still present in the medium, and the culture was still sensitive to subsequent treatment with this agent. A possible mechanism to explain these results in presented.

The inhibition pattern of streptovitacin A on KB cells which were treated in vitro under conditions simulating those found in vivo was determined.

No reversal of streptovitacin A cytotoxicity to KB cells was observed when mixtures of purines, pyrimidines, nucleosides, vitamins, amino acids, co-factors, Krebs' cycle intermediates, glucose, metals, or versene were added to the tissue culture medium.

* This work was supported in part by Contract No. SA-43-ph-1933, Cancer Chemotherapy National Service Center, National Institutes of Health.

Received 5/13/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.